trial

Vitamin D for Schizophrenia

NCTId NCT01759485
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 47 (actual)
Sponsored by Geha Mental Health Center
Primary completion 2016-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
47 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2014-05
Primary completion
2016-09
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Vitamin D3

Sponsors

Geha Mental Health CenterLead Sponsor

Sites

1 total
Petah Tikva, Israel

Facts & assertions

4 sourced
Enrollment
47
Phase
NA
Primary Completion Date
2016-09
Status
COMPLETED
relationships
The graph out of here
drug
Vitamin D3
drug
lead_sponsor
Geha Mental Health Center
company
indication
Schizophrenia
indication
Clozapine Resistant Schizophrenia
indication